logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10130634 B1

PDFFull Text
Expired
Date of Patent:
Nov. 20, 2018

Filed:

Jul. 24, 2014

Therapeutic agent for ophthalmic disease

Applicant:

Mitsubishi Tanabe Pharma Corporation, Osaka, JP;

Inventor:

Hidemitsu Higashi, Osaka, JP;

Assignee:

MITSUBISHI TANABE PHARMA CORPORATION, Osaka, JP;

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Timothy P Thomas

Assistant Examiner:

George W Kosturko

Int. Cl.
CPC ...
A61K 31/535 (2006.01); A61K 31/5377 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 265/30 (2006.01); C07D 513/04 (2006.01); A61K 31/5375 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/5375 (2013.01); C07D 265/30 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 513/04 (2013.01);
Abstract

The present invention provides a therapeutic agent or prophylactic agent for an ophthalmic disease caused by ocular angiogenesis, which contains a morpholine compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is a hydrogen atom and the like, or a pharmaceutically acceptable salt thereof as an active ingredient.

Find Patent Forward Citations

Quick Actions:

Higashi, Hidemitsu. (2018). Therapeutic agent for ophthalmic disease (U.S. Patent No. 10130634). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10130634

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…